Metrics have shown us that “the end is nigh”; well, it is for this page anyway! Our download statistics indicate that few of you read the words on this page, so we have decided that from January 2012 onwards 'From the editors' will put in an appearance only when needed. For example, as this is the December issue and effectively the end of 2011 for us, we can use this page to thank everyone who took the time to write for Nature Reviews Cancer this year and all of you who spared some of your precious time to peer review for us.
This space also enables us to tell you about some of the occasional extras that come with the journal. This month we have a poster on 'Proteasome inhibitors and cancer therapy', written by Q. Ping Dou. The poster covers the recent progress in this area — the approval in the United States of the use of bortezomib for patients with relapsed multiple myeloma, and additional proteasome inhibitors that have entered clinical trials. This poster is freely available thanks to support from Onyx Pharmaceuticals. Another rather unusual extra this month is to announce our debut on Twitter: @NatureRevCancer, please follow us!
This is a preview of subscription content, access via your institution
